These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 9056693)

  • 1. Spironolactone prevents Na+/H+ exchange enhancement in primary aldosteronism.
    Koren W; Koldanov R; Postnov IY; Postnov YV
    Am J Hypertens; 1997 Mar; 10(3):341-5. PubMed ID: 9056693
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased Na(+)-H+ exchange in red blood cells of patients with primary aldosteronism.
    Koren W; Postnov IY; Postnov YV
    Hypertension; 1997 Feb; 29(2):587-91. PubMed ID: 9040443
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of spironolactone on fluid volumes and adrenal steroids in primary aldosteronism.
    Ichikawa S; Tajima Y; Sakamaki T; Matsuo H; Kogure M; Hirano Y; Yagi S; Murata K
    Jpn Circ J; 1984 Nov; 48(11):1184-96. PubMed ID: 6502914
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mechanisms for nongenomic and genomic effects of aldosterone on Na+/H+ exchange in vascular smooth muscle cells.
    Miyata Y; Muto S; Kusano E
    J Hypertens; 2005 Dec; 23(12):2237-50. PubMed ID: 16269966
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alterations of calcium metabolism and of parathyroid function in primary aldosteronism, and their reversal by spironolactone or by surgical removal of aldosterone-producing adenomas.
    Rossi E; Sani C; Perazzoli F; Casoli MC; Negro A; Dotti C
    Am J Hypertens; 1995 Sep; 8(9):884-93. PubMed ID: 8541003
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence of primary hyperaldosteronism assessed by aldosterone/renin ratio and spironolactone testing.
    Hood S; Cannon J; Foo R; Brown M
    Clin Med (Lond); 2005; 5(1):55-60. PubMed ID: 15745200
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of spironolactone on cytosolic free sodium concentration in platelets from hypertensive patients with primary aldosteronism.
    Tepel M; Husseini S; Zidek W
    Eur J Clin Pharmacol; 1993; 44 Suppl 1():S51-2. PubMed ID: 8387426
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Red blood cell Na+/H+ exchange activity is insulin resistant in hypertensive patients.
    Romero JR; Rivera A; Conlin PR
    Clin Exp Hypertens; 2002 May; 24(4):277-87. PubMed ID: 12069358
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Erythrocyte Na(+)-H+ exchanger and Na(+)-Li+ countertransport activity in primary aldosteronism.
    Delva P; Pastori C; Degan M; Montesi G; Bassi A; Lechi A
    Eur J Clin Invest; 1994 Dec; 24(12):794-8. PubMed ID: 7705372
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Spironolactone inhibits the activity of the Na+/H+ exchanger in the aorta of mineralocorticoid-induced hypertensive rats.
    Carreño JE; Verdugo FJ; Contreras F; Montellano FA; Veloso S; Schalper KA; Sandoval M; Villanueva S; Marusic E; Irarrazabal CE
    J Renin Angiotensin Aldosterone Syst; 2015 Dec; 16(4):1225-31. PubMed ID: 25997821
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of spironolactone on urinary excretion of immunoreactive prostaglandin E in essential hypertension and primary aldosteronism.
    Chiba S; Abe K; Yasujima M; Irokawa N; Seino M; Sakurai Y; Sato M; Otsuka Y; Yoshinaga K
    Tohoku J Exp Med; 1978 Apr; 124(4):297-305. PubMed ID: 663929
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regression of left ventricular hypertrophy in patients with primary aldosteronism/low-renin hypertension on low-dose spironolactone.
    Ori Y; Chagnac A; Korzets A; Zingerman B; Herman-Edelstein M; Bergman M; Gafter U; Salman H
    Nephrol Dial Transplant; 2013 Jul; 28(7):1787-93. PubMed ID: 23378418
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of aldosterone and cortisol on human erythrocyte Na efflux.
    Gall G; Usher P; Melby JC; Klein R
    J Clin Endocrinol Metab; 1971 Apr; 32(4):555-61. PubMed ID: 5547272
    [No Abstract]   [Full Text] [Related]  

  • 14. Long-term cardiac effects of adrenalectomy or mineralocorticoid antagonists in patients with primary aldosteronism.
    Catena C; Colussi G; Lapenna R; Nadalini E; Chiuch A; Gianfagna P; Sechi LA
    Hypertension; 2007 Nov; 50(5):911-8. PubMed ID: 17893375
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enhanced Na+/H+ exchange in Cushing's syndrome reflects functional hypermineralocorticoidism.
    Koren W; Grienspuhn A; Kuznetsov SR; Berezin M; Rosenthal T; Postnov YV
    J Hypertens; 1998 Aug; 16(8):1187-91. PubMed ID: 9794723
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cell membrane cation transport systems during aldosterone antagonism.
    Lijnen P; Petrov V
    J Cardiovasc Pharmacol; 1996 Apr; 27(4):462-8. PubMed ID: 8847860
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of aldosterone in the antihypertensive effect of spironolactone in essential hypertension.
    Benraad H; Drayer J; Hoefnagels W; Kloppenborg P; Benraad T
    Clin Pharmacol Ther; 1978 Dec; 24(6):638-43. PubMed ID: 710023
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Primary Aldosteronism: Present and Future.
    Funder JW
    Vitam Horm; 2019; 109():285-302. PubMed ID: 30678860
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of amiloride and spironolactone on renal tubular function and central blood pressure in patients with arterial hypertension during baseline conditions and after furosemide: a double-blinded, randomized, placebo-controlled crossover trial.
    Matthesen SK; Larsen T; Vase H; Lauridsen TG; Jensen JM; Pedersen EB
    Clin Exp Hypertens; 2013; 35(5):313-24. PubMed ID: 22966789
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of de novo protein synthesis and calmodulin in rapid activation of Na(+)-H+ exchange of aldosterone in frog diluting segment.
    Cooper GJ; Hunter M
    J Physiol; 1996 Feb; 491 ( Pt 1)(Pt 1):219-23. PubMed ID: 9011614
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.